Yordanka Gluhcheva

Yordanka Gluhcheva

Auto-generated profile, based on publicly available information

Yordanka Gluhcheva

Institute of Experimental Morphology, Pathology and Anthropology with Museum, Bulgarian Academy of Sciences, Acad. Georgi Bonchev Street, Bl. 25, 1113 Sofia, Bulgaria

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2016 in Journal of Trace Elements in Medicine and Biology
Verified
Journal Article
Closed access
JIJuliana M. Ivanova
Juliana M. Ivanova
YGYordanka Gluhcheva
Yordanka Gluhcheva
DDDonika Dimova
Donika Dimova
EPEkaterina Pavlova
Ekaterina Pavlova
SASonja Arpadjan
Sonja Arpadjan

1 September 2020 in Chemico-Biological Interactions
Verified
Journal Article
Closed access
EPEmilia Petrova
Emilia Petrova
EPEkaterina Pavlova
Ekaterina Pavlova
TATinkov Alexey
Tinkov Alexey
OAOlga P. Ajsuvakova
Olga P. Ajsuvakova
ASAnatoly Skalny
Anatoly Skalny
YGYordanka Gluhcheva
Yordanka Gluhcheva

1 March 2020 in Journal of Trace Elements in Medicine and Biology
Verified
Journal Article
Closed access
EPEmilia Petrova
Emilia Petrova
YGYordanka Gluhcheva
Yordanka Gluhcheva
EPEkaterina Pavlova
Ekaterina Pavlova
IVIvelin Vladov
Ivelin Vladov
TVTsvetomil Voyslavov
Tsvetomil Voyslavov
JIJuliana M. Ivanova
Juliana M. Ivanova

29 May 2024 in Applied Sciences
Verified
Journal Article
Open access
PDF file
EZElissaveta Zvetkova
Elissaveta Zvetkova
IIIvan Mirchev Ivanov
Ivan Mirchev Ivanov
EKEugeni Vladimirov Koytchev
Eugeni Vladimirov Koytchev
NANadia Antonova
Nadia Antonova
YGYordanka Gluhcheva
Yordanka Gluhcheva
GKGeorgi Kostov
Georgi Kostov
Diabetes mellitus type 2 (DM2) is a hypercoagulable state with enhanced platelet (PLT) activation and increased clotting factor production. Simultaneously, the fibrinolytic cell system is inhibited due to the formation of clots with high fibrinolysis resistance. The stages of PLT “activation” have been well characterized microscopically, morphometrically, and nanomechanically using a light microscope, transmission electron microscope (TEM), scanning electron microscope (SEM), and atomic force microscope (AFM). Thrombocytes in an “activated” (procoagulant) state play a central role in two main biological processes: hemostasis and vascular vessel repair. Enhanced PLT reactivity in diabetic patients is considered a “pro-thrombotic” state. PLT hematometric indices are higher in retrospective and prospective studies, such as PLTs (count), MPV (mean platelet volume), PDW (platelet distribution width), PCR (platelet crit), and the PLTs/Ly ratio. The platelet indices MPV and PDW are higher in people with diabetes who have chronic vascular complications, and are statistically significant. PLT parameters/indices are useful biomarkers in the early diagnosis and prognosis of DM2. Precise studies of PLT activation state during DM2 may be useful for new diabetes (DM2) treatment strategies and effective therapeutic agents. Researchers have observed an association between MPV and medications such as insulin, metformin, and sulfonylureas using the blood glucose concentration attached to hemoglobin (HbA1c values) as markers of glycemic control in patients with diabetes. Computational modeling of PLT activation in DM2 is also a controlling factor for thrombocyte distribution and margination in blood vessels, both of which are associated with micro- and macrovascular disease in DM2. PLT-derived microRNAs (miRNAs) are novel molecular biomarkers for the diagnosis and prognosis of DM2, insulin resistance, and diabetes complications. Anti-platelet agents and natural plant products may also be effective in the prevention and secondary treatment of micro- and macrovascular complications in type 2 diabetes mellitus. To determine new ways of diagnosing, treating, predicting, and managing DM2 and its related vascular complications, we propose monitoring a combination of hematological, hemorheological, and hemostatic parameters (indices), which merit future studies.

13 September 2019 in Environmental Science and Pollution Research
Verified
Journal Article
Closed access
PDF file
KKKalina Kamenova
Kalina Kamenova
YGYordanka Gluhcheva
Yordanka Gluhcheva
PDPetar Dorkov
Petar Dorkov
JIJuliana M. Ivanova
Juliana M. Ivanova

1 December 2011 in Clinical Hemorheology and Microcirculation
Verified
Journal Article
Closed access
PDF file
YGY. Gluhcheva
Y. Gluhcheva
III. Ivanov
I. Ivanov
VAVasil Atanasov
Vasil Atanasov
NANadia Antonova
Nadia Antonova
JIJu. Ivanova
Ju. Ivanova
MMM. Mitewa
M. Mitewa
The study evaluated the affect of chronic cadmium (Cd) and monensin treatment on some hematological parameters and its relationship with the rheological variables. Adult male mice were subjected to chronic treatment with cadmium acetate [Cd(CH 3 COO) 2 × 2H 2 O] (group 1), Cd(CH 3 COO) 2 × 2H 2 O followed by treatment with low dose monensin (group 2) and Cd(CH 3 COO) 2 × 2H 2 O followed by high dose monensin treatment (group 3). Cd(CH 3 COO) 2 × 2H 2 O and deprotonated monensin were dissolved in distilled water and given daily to the experimental animals. Mice drinking distilled water served as a control group (group 4). Hematological parameters and erythrocyte morphology were evaluated in parallel with whole blood viscosity (WBV). Cd treatment reduced Hb and increased RDW. The addition of high dose monensin significantly improved erythrocytic indices compared to the control. Erythrocyte anisocytosis was observed in blood smears of Cd-treated mice corresponding to the increased RDW. WBV was significantly elevated in the experimental groups in the whole range of shear rates compared to the control group and in groups 2 and 3 was lower than in group 1 but remained higher compared to group 4. Correlations were found between WBV and RBC, Hb, Hct, MCV and RDW. The results suggest that hemorheological parameters such as WBV should be monitored in parallel with the hematological parameters when monensin is applied and heavy metal intoxication is suspected.